22 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Orna Therapeutics, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Next end date: 2026-10-23. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 22% above the DOL prevailing wage across 13 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Orna Therapeutics, Inc. sponsors H-1B workers, with 22 certified LCAs on file (FY2021–FY2026), including 2 in FY2026. The median certified salary is $110,000 (P25 $101,456, P75 $155,000). 100% of its certified filings meet or exceed the prevailing wage.
Orna Therapeutics, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 68% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 1 | 0 | 0 | 1 |
| FY2022 | 2 | 0 | 0 | 2 |
| FY2023 | 6 | 0 | 0 | 6 |
| FY2024 | 1 | 0 | 0 | 1 |
| FY2025 | 10 | 0 | 0 | 10 |
| FY2026 | 2 | 0 | 0 | 2 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Associate Scientist I-200-26094-757406 | $112,321/yr | II | Watertown, MA | Apr 03, 2026 | Certified |
Scientist I-200-26092-752514 | $99,143/yr | I | Watertown, MA | Apr 02, 2026 | Certified |
Associate Scientist I-200-25124-935097 | $109,000/yr | III | Watertown, MA | May 04, 2025 | Certified |
Associate Scientist I-200-25124-935083 | $109,200/yr | II | Watertown, MA | May 04, 2025 | Certified |
Senior Scientist I-200-25092-824212 | $155,000/yr | IV | Watertown, MA | Apr 02, 2025 | Certified |
Senior Scientist I-200-25090-815346 | $161,329/yr | IV | Watertown, MA | Mar 31, 2025 | Certified |
Principal Scientist I-200-25087-812417 | $189,405/yr | IV | Bethesda, MD | Mar 28, 2025 | Certified |
Associate Scientist I-200-25084-802614 | $108,395/yr | III | Watertown, MA | Mar 25, 2025 | Certified |
Associate Scientist I-200-25079-791216 | $110,000/yr | III | Watertown, MA | Mar 20, 2025 | Certified |
Senior Scientist I-200-25077-785949 | $150,900/yr | IV | Watertown, MA | Mar 18, 2025 | Certified |
Senior Scientist I-200-25062-738642 | $155,000/yr | III | Watertown, MA | Mar 03, 2025 | Certified |
Senior Scientist NGS I-200-24305-444691 | $155,000/yr | III | Watertown, MA | Oct 31, 2024 | Certified |
Senior Associate Scientist I-200-23290-436809 | $135,000/yr | II | Watertown, MA | Oct 17, 2023 | Certified |
Senior Research Associate, Molecular Biology I-200-23229-272438 | $85,365/yr | — | Watertown, MA | Aug 17, 2023 | Certified |
Research Associate, Nucleic Acid Process Sciences I-200-23121-978465 | $71,504/yr | I | Watertown, MA | Apr 30, 2023 | Certified |
Associate Scientist, In Vitro High Throughput Screening I-200-23083-875183 | $110,000/yr | III | Cambridge, MA | Mar 24, 2023 | Certified |
Associate Scientist, In Vitro High Throughput Screening I-200-23083-875334 | $110,000/yr | III | Cambridge, MA | Mar 24, 2023 | Certified |
Senior Research Associate I-200-22319-586499 | $90,000/yr | — | Cambridge, MA | Nov 14, 2022 | Certified |
Lead Engineer, IT Operations, Infrastructure and Security I-200-22223-410990 | $165,000/yr | IV | Cambridge, MA | Aug 11, 2022 | Certified |
Associate Director, Machine Learning and Computational Biolo I-200-21319-705365 | $200,000/yr | IV | Cambridge, MA | Nov 15, 2021 | Certified |
Associate Scientist I-200-21105-228292 | $90,000/yr | II | Cambridge, MA | Apr 15, 2021 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Mar and Apr — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
2 states · 3 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →